IMMUNOLOGIC DEFICIENCY IN PSORIATIC PATIENTS RECEIVING CYTOTOXIC DRUGS: THE SECONDARY RESPONSE.
D000017:ABO Blood-Group System; D000486:Allergy and Immunology; D000937:Antigen-Antibody Reactions; D000970:Antineoplastic Agents; D035843:Biomedical Research; D001789:Blood Group Antigens; D007153:Immunologic Deficiency Syndromes; D007166:Immunosuppressive Agents; D011565:Psoriasis; D014436:Typhoid-Paratyphoid Vaccines
D000017:ABO Blood-Group System; D000970:Antineoplastic Agents; D001789:Blood Group Antigens; D007166:Immunosuppressive Agents; D014436:Typhoid-Paratyphoid Vaccines
ABO FACTORS; ANTIGEN-ANTIBODY REACTIONS; ANTINEOPLASTIC AGENTS; BLOOD GROUPS; CLINICAL RESEARCH; IMMUNOLOGY; IMMUNOSUPPRESSIVE AGENTS; PSORIASIS; TYPHOID-PARATYPHOID VACCINES